当前位置:首页 - 行情中心 - 智飞生物(300122) - 财务分析

智飞生物

(300122)

  

流通市值:292.20亿  总市值:494.56亿
流通股本:14.14亿   总股本:23.94亿

智飞生物(300122)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润-3.05亿元,每股收益-0.13元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益3052559.88万元,未分配利润2693491.42万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产4834031.98万元,负债1781472.10万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入2,374,498,616.1126,069,711,361.4422,786,306,742.4318,258,441,511.25
营业总成本2,434,178,574.4723,192,418,166.6419,685,884,775.9915,281,723,020.21
营业利润-332,730,093.072,263,812,276.882,484,710,924.742,579,122,973.7
利润总额-333,117,143.242,253,691,570.882,477,954,662.482,572,704,157.62
净利润-305,140,593.282,018,478,513.912,150,622,937.942,234,319,364.61
其他综合收益----
综合收益总额-305,140,593.282,018,478,513.912,150,622,937.942,234,319,364.61
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计39,675,364,495.941,292,988,542.9345,458,060,346.5546,812,204,603.24
非流动资产合计8,664,955,347.558,616,625,292.478,251,514,241.98,032,922,341.93
资产总计48,340,319,843.4549,909,613,835.453,709,574,588.4554,845,126,945.17
流动负债合计17,263,558,980.8918,441,126,104.3721,649,036,529.0322,652,517,364.17
非流动负债合计551,162,047.74637,748,322.93618,896,277.89667,271,372.8
负债合计17,814,721,028.6319,078,874,427.322,267,932,806.9223,319,788,736.97
归属于母公司股东权益合计30,525,598,814.8230,830,739,408.131,441,641,781.5331,525,338,208.2
股东权益合计30,525,598,814.8230,830,739,408.131,441,641,781.5331,525,338,208.2
负债和股东权益合计48,340,319,843.4549,909,613,835.453,709,574,588.4554,845,126,945.17
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计3,846,455,890.3237,072,888,214.4528,515,112,725.119,964,897,857.09
经营活动现金流出小计3,542,300,800.5541,486,877,529.6531,580,081,449.8320,272,219,698.98
经营活动产生的现金流量净额304,155,089.77-4,413,989,315.2-3,064,968,724.73-307,321,841.89
投资活动现金流入小计10,364,945.64,759,655.974,655,142.174,641,142.17
投资活动现金流出小计149,039,120.66930,343,067.65700,478,076.61427,713,652.42
投资活动产生的现金流量净额-138,674,175.06-925,583,411.68-695,822,934.44-423,072,510.25
筹资活动现金流入小计5,944,474,956.7214,739,339,451.6410,265,312,326.465,898,318,287.2
筹资活动现金流出小计5,742,030,644.913,041,452,581.479,580,673,016.85,922,028,910.86
筹资活动产生的现金流量净额202,444,311.821,697,886,870.17684,639,309.66-23,710,623.66
汇率变动对现金及现金等价物的影响-122,611.31,252,023.78-801,413.27534,612.59
现金及现金等价物净增加额367,802,615.23-3,640,433,832.93-3,076,953,762.78-753,570,363.21
期末现金及现金等价物余额3,066,659,017.212,698,856,401.983,262,336,472.135,585,719,871.7
最新报告期:2025-04-25
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
西南证券杜向阳1.181.401.542025-04-25
TOP↑